Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Abpro Holdings Inc. (ABP : NSDQ)

• Company Description    Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $4.23 Daily Weekly Monthly 20 Day Moving Average: 13,244 shares Shares Outstanding: 2.72 (millions) Market Capitalization: $11.49 (millions) Beta: 0.02 52 Week High: $51.00 52 Week Low: $3.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -33.60% -33.48% 12 Week -28.68% -29.83% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 Summit Drive - Burlington,MA 01803 USA ph: 339-227-5961 fax: - None https://abpro.com

• General Corporate Information    Officers Miles Suk - Chief Executive Officer and Chairman of the Board Anthony D. Eisenberg - Director Soo Young Lee - Director Ian McDonald - Director Joanna Lord - Director Peer Information Abpro Holdings Inc. (CORR.) Abpro Holdings Inc. (RSPI) Abpro Holdings Inc. (CGXP) Abpro Holdings Inc. (BGEN) Abpro Holdings Inc. (GTBP) Abpro Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000847202 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/21/26 Share - Related Items Shares Outstanding: 2.72 Most Recent Split Date: 11.00 (0.03:1) Beta: 0.02 Market Capitalization: $11.49 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 47.55% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -344.76 06/30/25 - -241.16 Current Ratio 12/31/25 - - 09/30/25 - 0.07 06/30/25 - 0.15 Quick Ratio 12/31/25 - - 09/30/25 - 0.07 06/30/25 - 0.15 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - -6,720.77 Book Value 12/31/25 - - 09/30/25 - -5.84 06/30/25 - -7.66 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©